Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

89.79
-0.0400-0.04%
Post-market: 89.790.00000.00%19:52 EDT
Volume:2.82M
Turnover:253.16M
Market Cap:51.77B
PE:52.23
High:90.37
Open:89.89
Low:88.79
Close:89.83
52wk High:96.29
52wk Low:72.30
Shares:576.54M
Float Shares:575.03M
Volume Ratio:1.01
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.72
EPS(LYR):1.83
ROE:9.18%
ROA:8.37%
PB:4.88
PE(LYR):48.99

Loading ...

Citigroup Adjusts Edwards Lifesciences Price Target to $110 From $101

MT Newswires Live
·
Jul 08

Edwards Lifesciences is Maintained at Buy by Citigroup

Dow Jones
·
Jul 08

Edwards Lifesciences price target raised to $110 from $101 at Citi

TIPRANKS
·
Jul 08

Citi Keeps Their Buy Rating on Edwards Lifesciences (EW)

TIPRANKS
·
Jul 08

HII is Assessed “Awardable” in the U.S. Department of War CDAO Tradewinds Solutions Marketplace

GlobeNewswire
·
Jul 07

Edwards Lifesciences is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jul 07

Evercore ISI Adjusts Price Target on Edwards Lifesciences to $100 From $93

MT Newswires Live
·
Jul 06

Carvolix Says Edwards Lifesciences Holding Lifts Stake to 11.65% of Capital, 9.07% Voting Rights

Reuters
·
Jul 06

Edwards Lifesciences Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 02

Edwards Lifesciences CVP Daniel J. Lippis Disposes of Common Shares Worth $56,596.72

Reuters
·
Jul 01

Edwards Lifesciences is Maintained at Buy by BTIG

Dow Jones
·
Jun 30

VisionWave Signs Definitive Agreement to Acquire Controlling Interest in Meteor Aerospace

GlobeNewswire
·
Jun 30

BTIG Keeps Their Buy Rating on Edwards Lifesciences (EW)

TIPRANKS
·
Jun 30

BTIG Adjusts Price Target on Edwards Lifesciences to $110 From $100, Maintains Buy Rating

MT Newswires Live
·
Jun 30

Edwards Lifesciences Secures US FDA Approval for Ecliptis System

MT Newswires Live
·
Jun 30

BTIG says AtriCure should be ready to defend AtriClip share after Edwards nod

TIPRANKS
·
Jun 30

FDA posts approval of Edwards left atrial appendage system

TIPRANKS
·
Jun 30

Edwards Lifesciences Can Sustain Strong Revenue Growth on Technological Leadership, RBC Says

MT Newswires Live
·
Jun 30

Edwards Lifesciences Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 27

Edwards Lifesciences Posts Progress Trial Baseline Data on Moderate Aortic Stenosis Patients at New York Valves 2026

Reuters
·
Jun 26